Compare Globus Medical Inc. Class A Common Stock (GMED) vs Honeywell International Inc (HON) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

Honeywell International (HON) trades at $207.29, down 1.12% on the day, with bearish technical signals but strong fundamental metrics including a low P/E of 7.97 and robust ROE of 47.43%. The company recently completed its transformation into a pure-play automation business following spin-offs and secured a significant $300 million refinery project with Dangote. Earnings have consistently beaten expectations in recent quarters, with Q3 2026 results expected on October 22.

HON presents a compelling value opportunity with attractive valuation multiples and strong profitability, though near-term technical weakness and increasing debt levels warrant caution. Analyst consensus remains strongly bullish with a $259.25 price target representing 25% upside potential. The company's refocused automation strategy and recent contract wins provide growth catalysts, while execution risks and macroeconomic sensitivity pose challenges.